NVAX

Novavax, Inc. Press Releases

$5.44
*  
0.18
3.42%
Get NVAX Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading NVAX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NVAX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference
11/26/2014 8:33:00 AM - GlobeNewswire


U.S. FDA Grants Fast Track Designation to Novavax'' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization
11/20/2014 8:34:00 AM - GlobeNewswire


Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP
11/17/2014 4:07:00 PM - GlobeNewswire


Novavax to Present at the Jefferies Global Healthcare Conference
11/13/2014 9:34:00 AM - GlobeNewswire


Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects
11/10/2014 8:32:00 AM - GlobeNewswire


Novavax and Collaborators Make Multiple Presentations at the 9th International Respiratory Syncytial Virus Symposium in South Africa, November 9-13, 2014
11/6/2014 5:36:00 PM - GlobeNewswire


Novavax Reports Third Quarter 2014 Financial Results
11/5/2014 4:34:00 PM - GlobeNewswire


Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014
10/30/2014 8:32:00 AM - GlobeNewswire


U.S. FDA Grants Fast Track Designation to Novavax' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM)
10/29/2014 5:34:00 PM - GlobeNewswire


Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia
10/27/2014 7:32:00 AM - GlobeNewswire


Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia on Sunday, October 26
10/26/2014 10:10:00 AM - GlobeNewswire


Novavax to Present RSV Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia on Sunday, October 26
10/23/2014 4:24:00 PM - GlobeNewswire


Novavax Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies
10/15/2014 8:32:00 AM - GlobeNewswire


Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects
10/14/2014 8:36:00 AM - GlobeNewswire


Novavax'' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data
9/23/2014 8:31:00 AM - GlobeNewswire


Novavax' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data
9/23/2014 8:31:00 AM - GlobeNewswire


Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women
9/16/2014 4:08:00 PM - GlobeNewswire


Novavax to Host 2nd Annual Analyst and Investor Meeting
9/11/2014 5:22:00 PM - GlobeNewswire


ICAAC Presentation: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus in a Comparable Manner to Infants Prophy...
9/8/2014 9:25:00 AM - GlobeNewswire


ICAAC Presentation: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus in a Comparable Manner to Infants Prophylaxed With Palivizumab
9/8/2014 8:51:00 AM - GlobeNewswire


Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC
9/6/2014 11:01:00 AM - GlobeNewswire


CORRECTING and REPLACING -- Novavax to Present RSV Vaccine Preclinical Results at ICAAC
9/3/2014 6:29:00 PM - GlobeNewswire


Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC
9/3/2014 4:56:00 PM - GlobeNewswire